Jane Street Group LLC cut its holdings in Plexus Corp. (NASDAQ:PLXS - Free Report) by 24.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 32,662 shares of the technology company's stock after selling 10,671 shares during the quarter. Jane Street Group LLC owned about 0.12% of Plexus worth $4,465,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. Disciplined Growth Investors Inc. MN lifted its stake in Plexus by 0.3% in the second quarter. Disciplined Growth Investors Inc. MN now owns 2,109,047 shares of the technology company's stock valued at $217,611,000 after buying an additional 7,245 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its position in Plexus by 8.8% in the 2nd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,079,340 shares of the technology company's stock valued at $111,366,000 after acquiring an additional 87,574 shares in the last quarter. Earnest Partners LLC boosted its stake in Plexus by 3.0% in the 2nd quarter. Earnest Partners LLC now owns 788,196 shares of the technology company's stock worth $81,326,000 after purchasing an additional 23,074 shares during the period. Bank of New York Mellon Corp increased its holdings in Plexus by 7.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 453,308 shares of the technology company's stock worth $46,772,000 after purchasing an additional 31,099 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in Plexus by 0.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 421,903 shares of the technology company's stock worth $57,678,000 after purchasing an additional 2,886 shares in the last quarter. 94.45% of the stock is owned by institutional investors.
Insider Activity
In other Plexus news, CFO Patrick John Jermain sold 5,045 shares of the company's stock in a transaction on Monday, October 28th. The shares were sold at an average price of $143.13, for a total value of $722,090.85. Following the transaction, the chief financial officer now directly owns 24,602 shares in the company, valued at $3,521,284.26. The trade was a 17.02 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Victor (Pang Hau) Tan sold 3,000 shares of the firm's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $165.90, for a total transaction of $497,700.00. Following the sale, the insider now owns 5,605 shares of the company's stock, valued at approximately $929,869.50. This represents a 34.86 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 32,591 shares of company stock valued at $5,143,375. 2.39% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on PLXS. Needham & Company LLC upped their price objective on Plexus from $144.00 to $162.00 and gave the stock a "buy" rating in a research report on Friday, October 25th. Stifel Nicolaus boosted their target price on Plexus from $136.00 to $150.00 and gave the company a "hold" rating in a research note on Tuesday, December 10th. KeyCorp began coverage on shares of Plexus in a research note on Tuesday, October 22nd. They set a "sector weight" rating for the company. StockNews.com upgraded shares of Plexus from a "hold" rating to a "buy" rating in a report on Monday, November 18th. Finally, Benchmark increased their target price on shares of Plexus from $150.00 to $165.00 and gave the stock a "buy" rating in a report on Monday, October 28th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Plexus has a consensus rating of "Moderate Buy" and an average price target of $147.25.
Get Our Latest Stock Report on PLXS
Plexus Stock Down 3.0 %
Shares of NASDAQ:PLXS traded down $4.94 during trading on Wednesday, hitting $159.56. 250,595 shares of the company were exchanged, compared to its average volume of 137,629. Plexus Corp. has a fifty-two week low of $90.18 and a fifty-two week high of $170.07. The stock has a market cap of $4.32 billion, a price-to-earnings ratio of 39.79 and a beta of 0.90. The company has a current ratio of 1.51, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07. The firm has a fifty day moving average price of $154.08 and a two-hundred day moving average price of $130.92.
Plexus (NASDAQ:PLXS - Get Free Report) last issued its earnings results on Wednesday, October 23rd. The technology company reported $1.85 earnings per share for the quarter, topping analysts' consensus estimates of $1.55 by $0.30. The business had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.51%. The firm's revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.44 earnings per share. As a group, research analysts anticipate that Plexus Corp. will post 6.14 earnings per share for the current fiscal year.
Plexus Profile
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.